Pilot Study of Human Tear Proteins

University of Colorado, Denver63 enrolled

Overview

The significance of our study is in the importance of understanding the quality and quantity of proteins in the human tear film from diseased and non-diseased patients. This pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Eye Disease

Interventions

Eye ExaminationOTHER

Subjects receiving eye examination

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years of age and older * able to cooperate with tear sample collection * provide written informed consent Exclusion Criteria: * special populations (children, pregnant or lactating females, prisoners, etc) * refusal to sign sudy consent

Locations (1)

Rocky Mountain Lions Eye Institute

Aurora, Colorado, United States

Outcomes

Primary Outcomes

Plan Prospective Research

Pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion.

Time frame: Throughout study participation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.